Novo Nordisk A/S

Public limited companyCVR 24256790BagsværdActive

Novo Nordisk A/S is a public limited company, based in Bagsværd, active in manufacture of pharmaceutical preparations, founded in 1931. Measured by gross profit, it ranks no. 1 of 57 companies in the industry in the database. Profit has grown three years in a row. Operations are spread over 171 production units in 21 towns.

Follow
PDF reportCompare

Key figures · financial year 2025

RevenueDKK 309.1bn+6.4% vs. 2024
Net profitDKK 102.4bn+1.4% vs. 2024
EquityDKK 194bn+35.2% vs. 2024
Employees27,279latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit rose 2% (2024 → 2025), to DKK 250.3bn.
  • Revenue rose 6% (2024 → 2025), to DKK 309.1bn.
  • Net profit rose 1% (2024 → 2025), to DKK 102.4bn.
  • Equity rose 35% (2024 → 2025), to DKK 194bn.

Employees

  • 6,430 fewer employees than a year earlier: 27,279 (07/2026) against 33,709 (07/2025).

Management and owners, last 24 months

  • New in management: Maziar Doustdar (ceo, 07/08/2025), Britt Meelby Jensen (board member, 14/11/2025) and Lars Rebien Sørensen (chair of the board, 14/11/2025) (+12).
  • Stepped down: Sylvie Louise Grégoire (board member, 14/11/2025), Lars Fruergaard Jørgensen (ceo, 06/08/2025) and Anders Kaae (deputy board member, 26/03/2026) (+12).

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2016–2025 · amounts in DKK thousand

Equity and net profit

DKK 0DKK 20bnDKK 40bnDKK 60bnDKK 80bnDKK 100bnDKK 120bnDKK 140bnDKK 160bnDKK 180bnDKK 200bn2016201720182019202020212022202320242025
EquityNet profit
Financial figures for Novo Nordisk A/S
2016201720182019202020212022202320242025Change
Revenuenot statednot statednot statednot stated126,946,000140,800,000176,954,000232,261,000290,403,000309,064,000+6.4%
Gross profit94,597,00094,064,00094,214,000101,933,000106,014,000117,142,000148,506,000196,496,000245,881,000250,276,000+1.8%
Operating profit (EBIT)48,432,00048,967,00047,248,00052,483,00054,126,00058,644,00074,809,000102,574,000128,339,000127,658,000−0.5%
Profit before tax47,798,00048,680,00047,615,00048,553,00053,130,00059,080,00069,062,000104,674,000127,191,000130,540,000+2.6%
Net profit37,925,00038,130,00038,628,00038,951,00042,138,00047,757,00055,525,00083,683,000100,988,000102,434,000+1.4%
Total assets97,539,000102,355,000110,769,000125,612,000144,922,000194,508,000241,257,000314,486,000465,795,000542,902,000+16.6%
Equity45,269,00049,815,00051,839,00057,593,00063,325,00070,746,00083,486,000106,561,000143,486,000194,047,000+35.2%
Liabilities52,270,00052,540,00058,930,00068,019,00081,597,000123,762,000157,771,000207,925,000322,309,000348,855,000+8.2%
Cash and cash equivalents18,461,00017,158,00015,629,00015,411,00012,226,00010,719,00012,653,00014,392,00015,655,00026,464,000+69%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2016, 2017, 2018, 2019: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 50bnDKK 100bnDKK 150bnDKK 200bnDKK 250bn2016201720182019202020212022202320242025
Gross profitMedian, the industry (59 companies)

Signals from the financial statements

calculated from the 2025 figures
  • Profit for five years in a row

    Net result has been positive in 2021–2025.

    How is this calculated?

    Net result is positive in the five latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

10 financial years
Annual reports for Novo Nordisk A/S
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202527/03/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202428/03/2025The companyPDF not statedXBRL
202301/01/2023 – 31/12/202303/04/2024The companyPDF not statedXBRL
202201/01/2022 – 31/12/202227/03/2023The companyPDF not statedXBRL
202101/01/2021 – 31/12/202125/03/2022The companyPDF not statedXBRL
202001/01/2020 – 31/12/202026/03/2021The companyPDF not statedXBRL
201901/01/2019 – 31/12/201908/04/2020The companyPDFXBRL
201801/01/2018 – 31/12/201809/04/2019The companyPDFXBRL
201701/01/2017 – 31/12/201729/03/2018The companyPDFXBRL
201601/01/2016 – 31/12/201630/03/2017The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
05,00010,00015,00020,00025,00030,00035,00008/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

59 companies in the database

Comparison with the other companies in manufacture of pharmaceutical preparations based on the latest financial year.

Gross profitDKK 250.3bnNo. 1 of 57
Better than 100% of the companies in the industry
EquityDKK 194bnNo. 1 of 59
Better than 100% of the companies in the industry
Number of employees27,279No. 1 of 59
Better than 100% of the companies in the industry

Industry median: gross profit DKK 2.8m, net profit −DKK 2.2m, equity DKK 5.2m, 10 employees.

DKK 266kDKK 8.3mDKK 258mDKK 8bnDKK 79.6bnHere
Distribution of gross profit for 34 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with 1,000 employees or more177 companies in the comparison
No. 1of 147
Better than 100%
No. 1of 177
Better than 100%
Companies that are at least 30 years old10,276 companies in the comparison
No. 1of 10,152
Better than 100%
No. 1of 10,275
Better than 100%
All companies of type A/S18,025 companies in the comparison
No. 1of 17,786
Better than 100%
No. 4of 18,024
Better than 100%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Manufacture of pharmaceutical preparations
Gross profit
  1. Novo Nordisk A/SDKK 250.3bn
  2. H. Lundbeck A/SDKK 20.4bn
  3. Leo Pharma A/SDKK 8.2bn
Net profit
  1. Novo Nordisk A/SDKK 102.4bn
  2. H. Lundbeck A/SDKK 3.2bn
  3. Leo Pharma A/SDKK 2.5bn
Equity
  1. Novo Nordisk A/SDKK 194bn
  2. H. Lundbeck A/SDKK 24.9bn
  3. Leo Pharma A/SDKK 5.3bn
Employees
  1. Novo Nordisk A/S27,279
  2. H. Lundbeck A/S2,261
  3. Leo Pharma A/S1,047

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register

Subsidiaries are shown only if they are in the database.

Management

18 active registrations

Executive management

Executive management at Novo Nordisk A/S
NameRoleAppointed
Karsten Munk KnudsenDirector15/02/2018
Maziar DoustdarCEO07/08/2025

Board of directors

Board of directors at Novo Nordisk A/S
NameRoleAppointed
Kasim KutayBoard member23/03/2017
Mette Bøjer JensenBoard member22/03/2018
Elisabeth Dahl ChristensenBoard member24/03/2022
Britt Meelby JensenBoard member14/11/2025
Lars Rebien SørensenChair of the board14/11/2025
Cornelis de JongDeputy chair14/11/2025
Stephan EngelsBoard member14/11/2025
Hassan KassemDeputy board member26/03/2026
Désireé Jantzen AsgreenBoard member26/03/2026
Tanja VillumsenDeputy board member26/03/2026
Tamara SchmidtDeputy board member26/03/2026
Helena Ildiko SaxonBoard member26/03/2026
Ramona Audry SequeiraBoard member26/03/2026
Johannes Gerardus Joseph van de WinkelBoard member26/03/2026
Semsi Kilic MadsenBoard member26/03/2026
Trine Hartvig KristiansenDeputy board member26/03/2026
Former management (116)
Former management at Novo Nordisk A/S
NameRoleAppointedResigned
Randi Munch KrogsgaardDeputy board member28/11/193110/05/1994
Mads Ravn SørensenDirector28/11/193106/01/1993
Knud ØstergaardBoard member28/11/193103/05/1989
Kurt Anker NielsenDirector28/11/193113/11/2000
Jørgen RasmussenDeputy board member28/11/193102/06/1994
Erik SørensenDirector28/11/193118/11/1994
Steen RiisgaardDirector28/11/193113/11/2000
Gert Almind FrederiksenBoard member28/11/193130/06/2000
Allan PhilipDeputy chair28/11/193126/03/1998
Sonnich Jacob FrylandDirector28/11/193115/11/1995
Niels Wilhelm HolmDirector28/11/193108/05/1990
Henry BrennumBoard member28/11/193131/08/1990
Henry BrennumCEO28/11/193131/08/1990
Bent IversenBoard member28/11/193103/05/1989
Olav HauganBoard member28/11/193110/05/1994
Ulrik Vilhelm LassenDirector28/11/193126/06/1992
Lene AndersenBoard member28/11/193108/05/1990
Vagn AndersenChair of the board28/11/193123/03/2000
Ole ScherfigBoard member28/11/193102/04/2000
Jens Henrik EilertsenDeputy board member28/11/193110/05/1994
Jaromir RuzickaBoard member28/11/193113/11/2000
Kurt Stenager JakobsenDirector28/11/193109/08/1991
Kurt Anker NielsenDirector28/11/193108/05/1990
Lene Priem PedersenDeputy board member28/11/193108/05/1990
Per RosendalDeputy board member28/11/193108/05/1990
Preben John KristensenBoard member28/11/193125/03/1999
Johnny Michaelsen ChristiansenDeputy board member28/11/193108/05/1990
Morten Boje MunkBoard member28/11/193102/04/2001
Flemming JunkerBoard member28/11/193110/05/1994
Jan ØstBoard member28/11/193108/05/1990
Hans JensenDeputy board member28/11/193110/05/1994
Hanne Brieghel FabriciusBoard member28/11/193126/03/1998
Jette LundgrenBoard member28/11/193110/05/1994
Christian Bidstrup ClausenDeputy board member28/11/193126/03/1998
Tove Daa VitekBoard member28/11/193112/03/2002
Bente Anette SkriverBoard member28/11/193126/03/1998
Thomas FærgemanDeputy board member28/11/193126/03/1998
Niels Boye LorentsenDeputy board member28/11/193126/03/1998
Bruce Leonard Andrew CarterDirector28/11/193117/12/1997
Henrik GürtlerDirector28/11/193113/11/2000
Børge Viktor Ringgård SørensenDeputy board member28/11/193110/05/1994
Max Johannes LarsenDeputy board member28/11/193126/03/1998
Jan LeschlyBoard member28/11/193128/06/1990
Stig StrøbækBoard member26/03/199824/03/2022
Karl Heinz WolffDeputy board member26/03/199812/03/2002
Jan Ulf Sigvard JohanssonBoard member26/03/199809/03/2005
Mads ØvlisenChair of the board13/11/200008/03/2006
Mads ØvlisenCEO13/11/200013/11/2000
Hans Kristian WerdelinBoard member13/11/200013/11/2000
Niels JacobsenBoard member13/11/200012/03/2008
Palle MarcusChair of the board13/11/200013/11/2000
Kåre SchultzDirector13/11/200030/04/2015
Lars Rebien SørensenCEO13/11/200031/12/2016
Lars Anders Almblom JørgensenDirector13/11/200031/03/2006
Jesper BrandgaardDirector13/11/200015/04/2019
Ulla MorinBoard member13/11/200013/11/2000
Anne Marie Handrup KvernelandBoard member13/11/200024/03/2022
Mads Krogsgaard ThomsenDirector13/11/200028/02/2021
Jørgen Wedel PetersenBoard member13/11/200021/03/2012
Kurt Walter BrinerBoard member13/11/200018/03/2009
Johnny HenriksenBoard member12/03/200224/03/2010
Jannie FuhlendorffDeputy board member12/03/200208/03/2006
Søren Steenfeldt-JensenDeputy board member12/03/200208/03/2006
Lise KingoDirector22/03/200224/11/2014
Kurt Anker NielsenBoard member16/03/200420/03/2013
Henrik GürtlerBoard member09/03/200520/03/2014
Sten ScheibyeChair of the board08/03/200620/03/2013
Ole LissauerDeputy board member08/03/200620/03/2014
Søren Thuesen PedersenBoard member08/03/200622/03/2018
Søren Bjørn FriisDeputy board member08/03/200620/03/2014
Caspar AndreisDeputy board member08/03/200624/03/2010
Pamela Josephine KirbyBoard member12/03/200823/03/2011
Hannu Ragnvald RyöppönenBoard member18/03/200919/03/2015
Knud Edgar Striib NielsenDeputy board member24/03/201020/03/2014
Janus Christian KrarupDeputy board member24/03/201020/03/2014
Ulrik Joakim Hjulmand-LassenBoard member24/03/201020/03/2014
Thomas Paul KoestlerBoard member23/03/201118/03/2016
Bruno Francois Jules AngeliciBoard member23/03/201123/03/2017
Elizabeth Anne HewittBoard member21/03/201225/03/2021
Lars Fruergaard JørgensenDirector31/01/201331/12/2016
Jakob RiisDirector31/01/201301/09/2016
Jeppe ChristiansenDeputy chair20/03/201323/03/2022
Göran AndoChair of the board20/03/201322/03/2018
Michael MunksøDeputy board member20/03/201422/03/2018
Désireé Jantzen AsgreenDeputy board member20/03/201422/03/2018
Liselotte Sofie Hyveled-NielsenBoard member20/03/201422/03/2018
Anders KaaeDeputy board member20/03/201421/03/2018
Mette Bøjer JensenDeputy board member20/03/201421/03/2018
Helge LundBoard member20/03/201419/03/2015
Eivind Drachmann KoldingBoard member19/03/201518/03/2016
Sylvie Louise GrégoireBoard member19/03/201514/11/2025
Mary Teresa SzelaBoard member19/03/201516/05/2017
Brian Fredrick DanielsBoard member18/03/201625/03/2021
Henrik Ehlers WulffDirector01/09/201631/12/2023
Lars Fruergaard JørgensenCEO01/01/201706/08/2025
Helge LundBoard member23/03/201721/03/2018
Lars GreenDirector01/07/201731/08/2019
Camilla SylvestDirector01/10/201731/12/2023
Anders KaaeDeputy board member22/03/201826/03/2026
Helge LundChair of the board22/03/201814/11/2025
Andreas Helmut FibigBoard member22/03/201814/11/2025
Martin William MackayBoard member22/03/201814/11/2025
Thomas RantzauBoard member22/03/201831/01/2026
Tanja VillumsenDeputy board member22/03/201830/01/2026
Jesper ThorningDeputy board member22/03/201826/03/2026
Karina Bonde LenauDeputy board member22/03/201826/03/2026
Laurence DebrouxBoard member21/03/201914/11/2025
Monique Patricia CarterDirector09/08/201907/03/2023
Marcus SchindlerDirector01/03/202131/12/2023
Martin Holst LangeDirector01/03/202131/12/2023
Henrik PoulsenBoard member25/03/202123/03/2022
Henrik PoulsenDeputy chair24/03/202214/11/2025
Jeppe ChristiansenBoard member24/03/202223/03/2023
Liselotte Sofie Hyveled-NielsenBoard member24/03/202226/03/2026
Choi Lai Christina LawBoard member24/03/202214/11/2025
Tanja VillumsenBoard member31/01/202625/03/2026

Signing rule: Selskabet forpligtes ved underskrift (i) af to direktører i forening, (ii) af en direktør eller et bestyrelsesmedlem i forening med bestyrelsens formand eller næstformand eller (iii) af den samlede bestyrelse.

Address and production units

171 active production units
Production units
Production unitAddressEmployeesP number
Novo Nordisk A/S - DGHallas Alle 1, 4400 Kalundborg3,9751007675697
Novo Nordisk A/S - G8, x9 m.fl.Novo Nordisk Park 99, 2760 Måløv3,1871007676146
Novo Nordisk A/S - 25A-BBrennum Park 25A, 3400 Hillerød2,8911007676162
NOVO NORDISK A/S - VTxVandtårnsvej 112, 2860 Søborg2,4871017661449
Novo Nordisk A/S - GSA, GSB, GSC, GSD, GSF, GSGGirostrøget 1, 2630 Taastrup1,5821030113930
NOVO NORDISK A/S - NN1Novo Alle 1, 2880 Bagsværd1,4951006455042
Novo Nordisk A/S - 1FGHSmørmosevej 1, 2880 Bagsværd1,2511017673099
NOVO NORDISK A/S - HAxHagedornsvej 1, 2820 Gentofte1,0591010468147
Novo Nordisk A/S - LP42Lautrupparken 42, 2750 Ballerup8751029791909
Novo Nordisk A/S - 6ABSmørmosevej 17, 2880 Bagsværd8291019129256
Novo Nordisk A/S - NN2Krogshøjvej 44, 2880 Bagsværd7231019126583
Novo Nordisk A/S - LH85Lyngby Hovedgade 85, 2800 Kongens Lyngby6541031030133
Novo Nordisk A/S - 24ABrennum Park 24A, 3400 Hillerød6361027261317
Novo Nordisk A/S - VTEØstmarken 3A, 2860 Søborg6181028956890
Novo Nordisk A/S - F1Novo Nordisk Park 131, 2760 Måløv5851027626366

Showing 15 of 171 units (sorted by employees).

Purpose

Selskabets formål er at forske i, udvikle, producere og markedsføre farmaceutiske, medicinske og tekniske produkter og ydelser samt anden dertil knyttet virksomhed efter bestyrelsens nærmere bestemmelse. Selskabet tilstræber at drive sin virksomhed på økonomisk, miljømæssigt og socialt ansvarlig vis.

The purpose is quoted from the register in Danish.

Changes year by year

147 registered events
202618 changesaccounts 1 · management 17
  • Annual report for 2025 published
  • Helena Ildiko Saxon appointed board member
  • Tanja Villumsen appointed deputy board member
  • Johannes Gerardus Joseph van de Winkel appointed board member
  • Ramona Audry Sequeira appointed board member
  • Tamara Schmidt appointed deputy board member
  • Trine Hartvig Kristiansen appointed deputy board member
  • Semsi Kilic Madsen appointed board member
  • Hassan Kassem appointed deputy board member
  • Désireé Jantzen Asgreen appointed board member
  • Liselotte Sofie Hyveled-Nielsen stepped down as board member
  • Anders Kaae stepped down as deputy board member
  • Jesper Thorning stepped down as deputy board member
  • Karina Bonde Lenau stepped down as deputy board member
  • Tanja Villumsen stepped down as board member
  • Tanja Villumsen appointed board member
  • Thomas Rantzau stepped down as board member
  • Tanja Villumsen stepped down as deputy board member
202514 changesmanagement 13 · accounts 1
  • Lars Rebien Sørensen appointed chair of the board
  • Britt Meelby Jensen appointed board member
  • Stephan Engels appointed board member
  • Cornelis de Jong appointed deputy chair
  • Choi Lai Christina Law stepped down as board member
  • Henrik Poulsen stepped down as deputy chair
  • Laurence Debroux stepped down as board member
  • Martin William Mackay stepped down as board member
  • Helge Lund stepped down as chair of the board
  • Andreas Helmut Fibig stepped down as board member
  • Sylvie Louise Grégoire stepped down as board member
  • Maziar Doustdar appointed ceo
  • Lars Fruergaard Jørgensen stepped down as ceo
  • Annual report for 2024 published
20242 changescapital 1 · accounts 1
  • Share capital changed from 451,000,000 DKK to 446,500,000 DKK
  • Annual report for 2023 published
20238 changesmanagement 6 · capital 1 · accounts 1
  • Marcus Schindler stepped down as director
  • Martin Holst Lange stepped down as director
  • Camilla Sylvest stepped down as director
  • Henrik Ehlers Wulff stepped down as director
  • Share capital changed from 456,000,000 DKK to 451,000,000 DKK
  • Annual report for 2022 published
  • Jeppe Christiansen stepped down as board member
  • Monique Patricia Carter stepped down as director
20229 changescapital 1 · accounts 1 · management 7
  • Share capital changed from 462,000,000 DKK to 456,000,000 DKK
  • Annual report for 2021 published
  • Choi Lai Christina Law appointed board member
  • Jeppe Christiansen appointed board member
  • Henrik Poulsen appointed deputy chair
  • Liselotte Sofie Hyveled-Nielsen appointed board member
  • Elisabeth Dahl Christensen appointed board member
  • Henrik Poulsen stepped down as board member
  • Jeppe Christiansen stepped down as deputy chair
20217 changescapital 1 · accounts 1 · management 5
  • Share capital changed from 470,000,000 DKK to 462,000,000 DKK
  • Annual report for 2020 published
  • Henrik Poulsen appointed board member
  • Brian Fredrick Daniels stepped down as board member
  • Elizabeth Anne Hewitt stepped down as board member
  • Marcus Schindler appointed director
  • Martin Holst Lange appointed director
20202 changescapital 1 · accounts 1
  • Share capital changed from 480,000,000 DKK to 470,000,000 DKK
  • Annual report for 2019 published
20195 changesmanagement 3 · capital 1 · accounts 1
  • Lars Green stepped down as director
  • Monique Patricia Carter appointed director
  • Share capital changed from 490,000,000 DKK to 480,000,000 DKK
  • Annual report for 2018 published
  • Laurence Debroux appointed board member
201819 changescapital 1 · accounts 1 · management 17
  • Share capital changed from 500,000,000 DKK to 490,000,000 DKK
  • Annual report for 2017 published
  • Anders Kaae appointed deputy board member
  • Martin William Mackay appointed board member
  • Mette Bøjer Jensen appointed board member
  • Thomas Rantzau appointed board member
  • Tanja Villumsen appointed deputy board member
  • Helge Lund appointed chair of the board
  • Jesper Thorning appointed deputy board member
  • Andreas Helmut Fibig appointed board member
  • Karina Bonde Lenau appointed deputy board member
  • Michael Munksø stepped down as deputy board member
  • Désireé Jantzen Asgreen stepped down as deputy board member
  • Liselotte Sofie Hyveled-Nielsen stepped down as board member
  • Göran Ando stepped down as chair of the board
  • Helge Lund stepped down as board member
  • Mette Bøjer Jensen stepped down as deputy board member
  • Anders Kaae stepped down as deputy board member
  • Karsten Munk Knudsen appointed director
20179 changesmanagement 7 · capital 1 · accounts 1
  • Camilla Sylvest appointed director
  • Lars Green appointed director
  • Mary Teresa Szela stepped down as board member
  • Share capital changed from 510,000,000 DKK to 500,000,000 DKK
  • Annual report for 2016 published
  • Kasim Kutay appointed board member
  • Helge Lund appointed board member
  • Bruno Francois Jules Angelici stepped down as board member
  • Lars Fruergaard Jørgensen appointed ceo
20167 changesmanagement 6 · capital 1
  • Lars Fruergaard Jørgensen stepped down as director
  • Henrik Ehlers Wulff appointed director
  • Jakob Riis stepped down as director
  • Share capital changed from 520,000,000 DKK to 510,000,000 DKK
  • Brian Fredrick Daniels appointed board member
  • Eivind Drachmann Kolding stepped down as board member
  • Thomas Paul Koestler stepped down as board member
20155 changescapital 1 · management 4
  • Share capital changed from 530,000,000 DKK to 520,000,000 DKK
  • Mary Teresa Szela appointed board member
  • Sylvie Louise Grégoire appointed board member
  • Eivind Drachmann Kolding appointed board member
  • Helge Lund stepped down as board member
20149 changescapital 1 · management 8
  • Share capital changed from 550,000,000 DKK to 530,000,000 DKK
  • Helge Lund appointed board member
  • Mette Bøjer Jensen appointed deputy board member
  • Anders Kaae appointed deputy board member
  • Michael Munksø appointed deputy board member
  • Désireé Jantzen Asgreen appointed deputy board member
  • Liselotte Sofie Hyveled-Nielsen appointed board member
  • Ulrik Joakim Hjulmand-Lassen stepped down as board member
  • Knud Edgar Striib Nielsen stepped down as deputy board member
20135 changescapital 1 · management 4
  • Share capital changed from 560,000,000 DKK to 550,000,000 DKK
  • Göran Ando appointed chair of the board
  • Jeppe Christiansen appointed deputy chair
  • Lars Fruergaard Jørgensen appointed director
  • Jakob Riis appointed director
20122 changescapital 1 · management 1
  • Share capital changed from 580,000,000 DKK to 560,000,000 DKK
  • Elizabeth Anne Hewitt appointed board member
20113 changescapital 1 · management 2
  • Share capital changed from 600,000,000 DKK to 580,000,000 DKK
  • Thomas Paul Koestler appointed board member
  • Bruno Francois Jules Angelici appointed board member
20103 changescapital 1 · management 2
  • Share capital changed from 620,000,000 DKK to 600,000,000 DKK
  • Ulrik Joakim Hjulmand-Lassen appointed board member
  • Knud Edgar Striib Nielsen appointed deputy board member
20091 changecapital 1
  • Share capital changed from 634,000,000 DKK to 620,000,000 DKK
20082 changescapital 1 · industry 1
  • Share capital changed from 646,960,000 DKK to 634,000,000 DKK
  • Industry changed to Manufacture of pharmaceutical preparations (212000)
20071 changecapital 1
  • Share capital changed from 673,920,000 DKK to 646,960,000 DKK
20061 changecapital 1
  • Share capital changed from 709,388,320 DKK to 673,920,000 DKK
20021 changeaddress 1
  • Moved to Novo Alle 1, 2880 Bagsværd
20011 changecapital 1
  • Share capital changed from 754,388,320 DKK to 709,388,320 DKK
20001 changeownership 1
  • Novo Holdings A/S registered as owner (25%)
19991 changeindustry 1
  • Industry changed to Aluminium production (244200)
19981 changecapital 1
  • Share capital changed from 750,291,720 DKK to 754,388,320 DKK
19961 changemerger 1
  • Merger registered in CVR
19922 changescapital 2
  • Share capital changed from 747,461,900 DKK to 750,291,720 DKK
  • Share capital changed from 737,925,980 DKK to 747,461,900 DKK
19911 changecapital 1
  • Share capital changed from 632,508,000 DKK to 737,925,980 DKK
19902 changesname 1 · merger 1
  • Name changed from NOVO-NORDISK A/S to NOVO NORDISK A/S
  • Merger registered in CVR
19893 changesname 1 · capital 1 · merger 1
  • Name changed from NOVO INDUSTRI A/S to NOVO-NORDISK A/S
  • Share capital changed from 509,744,400 DKK to 632,508,000 DKK
  • Merger registered in CVR
19311 changefounded 1
  • Registered as NOVO INDUSTRI A/S

Related companies

Same industry in Gladsaxe

See all →

Same people in management

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 23/10/2026.

View in CVRReport a correction